OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders	68
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder	26
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Netwo	25
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment	21
Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology	20
mHealth in affective disorders: hype or hope? A focused narrative review	20
Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial	20
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study	17
Antidepressant psychopharmacology: is inflammation a future target?	17
Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials	15
A systematic review of studies with clinician-rated scales on the pharmacological treatment of delusional disorder	15
Managing dissociative symptoms following the use of esketamine nasal spray: a case report	14
Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis	13
The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study	13
Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report	13
Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study	13
Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain	13
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control	12
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study	12
Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer’s disease	11
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial	11
Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial	11
Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials	11
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study	10
Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies	10

Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain	9
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?	9
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder	9
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	9
Vortioxetine improves cognition in mild cognitive impairment	9
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	9
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study	9
Infection is associated with elevated serum concentrations of antipsychotic drugs	8
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts	8
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder	8
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	8
The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study	8
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	8
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial	8
Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer’s disease: a systematic review	8
Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort	8
Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder	8
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression	7
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study	7
Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder	7
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	7
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence	7
Estimation of lithium clearance in patients with bipolar disorder	7
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding	7
Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions	7
Clinical specificity profile for novel rapid acting antidepressant drugs	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data	6
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study	5
Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review	5
Risk of conversion to bipolar disorder in patients with late-onset major depression	5
Eosinophilic pneumonia during treatment with clozapine: reports from a retrospective case series	5
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10	5
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	5
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	5
Ophthalmic adverse effects of lithium	5
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	5
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	5
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	5
Poor performance of the ‘child Reading the Mind in the Eyes Test’ correlates with poorer social-emotional functioning in children with attention-deficit/hyperactivity disorder	5
The importance of monitoring renal function and concomitant medication to avoid toxicity in patients taking lithium	5
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019	5
Benzodiazepine exposure in subjects with incident Alzheimer’s disease and related syndromes in France: a longitudinal study 2011–2017	5
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	4
The efficacy and safety in attention deficit hyperactivity disorder of second-generation antipsychotics and other medications for hyperactivity in children and adolescents with autism: a meta-analysis	4
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	4
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	4
Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study	4
Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability	4
Paradoxical effect of statin medication on depressive disorder in first-ever ischemic stroke patients: possible antidepressant-like effect prestroke and the opposite in continuous medication poststrok	4

Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials	4
Effects of medications on ventricular repolarization in children with attention deficit hyperactivity disorder	4
Resurrecting the discussion on neurotoxicity of lithium at therapeutic levels	4
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial	4
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	4
Can bupropion treat COVID-19–induced brain fog? A case series	4
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute sch	4
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	4
Pharmacologic treatment of depression in Alzheimer’s disease	4
Clinical outcomes after clozapine discontinuation in responders versus nonresponders: a retrospective chart review	4
Lamotrigine-induced mania: warning report for the identification of vulnerable populations and expert clinical recommendations for prescription	4
The role of personality traits in following quarantine orders during the COVID-19 pandemic	3
Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system	3
Psychopharmacology: past, present and future	3
Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database	3
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	3
The clinical intervention choice for pediatric tic disorder patients from a tertiary children’s hospital in China: a large-scale retrospective study based on electronic medical records	3
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial	3
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	3
Does tramadol dependence impair cognitive functions?	3
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	3
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	3
Social withdrawal and neurocognitive correlates in schizophrenia	3
Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports	3
Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia	2
Case report: asenapine and anticholinergic toxicity	2
Open issues in bipolar and antipsychotic treatments	2
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial	2
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study	2
Allergic reaction induced by subcutaneous administration of ketamine: a case report	2
Plasma prolidase levels are high in schizophrenia but not in first-episode psychosis	2
On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents	2
Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia	2
Predictive factors of long-term follow-up in treatment of Korean alcoholics with naltrexone or acamprosate	2
The Gordian knot of the immune-redox systems’ interactions in psychosis	2
Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features	2
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	2
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	2
Ketamine for depression: a potential role in requests for Medical Aid in Dying?	2
DRESS syndrome: quetiapine associated case report and literature review	2
Neuroscience-based nomenclature as a teaching tool, introduction and pilot study	2
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	2
Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial	2
Bilateral pedal edema associated with lurasidone: a case report	2
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	2
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	2
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	2
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	2
Case series on aripiprazole and dopamine supersensitivity psychosis	2
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder	2
Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case report	2
Suicidality and psychotic episodes after starting aripiprazole: two case reports	2
Dissociative episode and panic attacks triggered by pitolisant in a narcoleptic patient	2
The association of antidepressant monotherapy and weight change in a Middle Eastern psychiatric population	2